A critical advance in cancer investigation is occurring with the use of nanobodies to reactivate mutated p53. This vital cancer protector protein is frequently inactivated in many types of malignancies, leading https://thekiwisocial.com/story7566922/nanobodies-revive-the-p53-protein-the-new-pathway-for-cancer-management